As an illustration, we show how this scheme enabled a scalable approach for comparing the relative contributions of the key tissues involved in T2D pathogenesis (i.e., those controlling insulin secretion and action) by allowing us to delineate probabilistic tissue scores at individual genetic signals (deemed “tissue-of-action” or TOA scores). This evidence concerns the gene INS and type 2 diabetes mellitus.